Paviovian Conditioning of Injured Spinal Cord Systems

受损脊髓系统的帕维奥调理

基本信息

  • 批准号:
    7162156
  • 负责人:
  • 金额:
    $ 6.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-01-01 至 2008-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The isolated spinal cord is inherently capable of learning about Pavlovian and instrumental relationships. Little is known, however, about the ways in which these two forms of learning may interact. The current studies aim to further knowledge of spinal learning, and also to take our empirical understanding of learning n the cord to a clinical level. Previous studies have shown that uncontrollable electrical stimulation undermines the plasticity of the cord producing an instrumental learning deficit that lasts for up to 48 hrs. Uncontrollable stimulation also undermines the recovery of function after a spinal contusion injury. The aim of this proposal is to examine spinal cord mechanisms that enable, and protect plasticity within the spinal cord. Preliminary results suggest that 'predictability' can protect plasticity in the isolated cord. Rats treated with predictable (Pavlovian) shock are subsequently able to learn an instrumental relationship, whereas unpredictable shock results in the learning deficit. The experiments we propose further examine the interactions between predictability and plasticity. First, we will examine whether establishing a Pavlovian relationship in spinal neurons can immunize or reverse the detrimental effects of uncontrollable electrical stimulation. A Pavlovian relationship will be established by applying a weak shock to the tail (CS) immediately before a stronger shock to the tibialis anterior muscle (US). Rats will be treated with Pavlovian conditioning before or after uncontrollable shock and their capacity to learn will be assessed using an instrumental task. We will then examine neurobiological cascades that modulate plasticity. Preliminary studies suggest that a CS can produce a ?-opioid mediated antinociception, and ? agonists are able to undermine the induction of the instrumental learning deficit produced with uncontrollable shock. The proposed studies will examine whether the protective effects of the CS on plasticity also depend on a ligand that acts on the ? receptor. A ? antagonist (nor BNI, i.t.) will be administered concurrently with the CS to determine whether this undermines the protective effects. Finally, using a variety of motor and sensory assays, we will examine the implications of Pavlovian conditioning for the recovery of function after a contusion injury. An understanding of spinal cord plasticity, how it is disrupted, and how it can be restored, is essential to the development of new procedures that promote recovery after a spinal injury.
描述(申请人提供):分离的脊髓具有学习巴甫洛夫关系和器质性关系的能力。然而,人们对这两种学习方式的相互作用知之甚少。目前的研究旨在加深对脊髓学习的了解,并将我们对脊髓学习的经验理解提升到临床水平。先前的研究表明,不可控的电刺激会破坏脊髓的可塑性,导致长达48小时的工具性学习缺陷。无法控制的刺激也会破坏脊柱挫伤后功能的恢复。这项建议的目的是检查脊髓机制,使脊髓内的可塑性,并保护。初步结果表明,“可预见性”可以保护分离的脐带的可塑性。接受可预测(巴甫洛夫)休克治疗的大鼠随后能够学习一种工具性关系,而不可预测的休克会导致学习缺陷。我们提出的实验进一步检验了可预测性和可塑性之间的相互作用。首先,我们将研究在脊髓神经元中建立巴甫洛夫关系是否可以免疫或逆转不可控电刺激的有害影响。巴甫洛夫关系将通过在对胫骨前肌(US)施加更强的电击之前立即对尾部(CS)施加弱电击来建立。在无法控制的休克之前或之后,大鼠将接受巴甫洛夫条件反射治疗,并将使用工具性任务评估它们的学习能力。然后,我们将研究调节可塑性的神经生物学级联反应。初步研究表明,CS可产生?-阿片介导的抗伤害性感觉。激动剂能够破坏由于无法控制的休克而产生的工具性学习缺陷的诱导。拟议的研究将检验CS对可塑性的保护作用是否也依赖于作用于?受体。A?拮抗剂(Nor BNI,I.T.)将与CS同时给药,以确定这是否会破坏保护作用。最后,使用各种运动和感觉分析,我们将检验巴甫洛夫条件反射对挫伤后功能恢复的影响。了解脊髓的可塑性,它是如何被破坏的,以及如何恢复它,对于开发促进脊髓损伤后恢复的新程序是至关重要的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHELLE A HOOK其他文献

MICHELLE A HOOK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHELLE A HOOK', 18)}}的其他基金

Morphine undermines recovery of function after SCI: Neurobiological mechanisms
吗啡会破坏 SCI 后功能的恢复:神经生物学机制
  • 批准号:
    8617260
  • 财政年份:
    2011
  • 资助金额:
    $ 6.11万
  • 项目类别:
Morphine undermines recovery of function after SCI: Neurobiological mechanisms
吗啡会破坏 SCI 后功能的恢复:神经生物学机制
  • 批准号:
    8234030
  • 财政年份:
    2011
  • 资助金额:
    $ 6.11万
  • 项目类别:
Morphine undermines recovery of function after SCI: Neurobiological mechanisms
吗啡会破坏 SCI 后功能的恢复:神经生物学机制
  • 批准号:
    8086576
  • 财政年份:
    2011
  • 资助金额:
    $ 6.11万
  • 项目类别:
Morphine undermines recovery of function after SCI: Neurobiological mechanisms
吗啡会破坏 SCI 后功能的恢复:神经生物学机制
  • 批准号:
    8426179
  • 财政年份:
    2011
  • 资助金额:
    $ 6.11万
  • 项目类别:
Paviovian Conditioning of Injured Spinal Cord Systems
受损脊髓系统的帕维奥调理
  • 批准号:
    7030106
  • 财政年份:
    2006
  • 资助金额:
    $ 6.11万
  • 项目类别:
The Effects of Morphine on Sensory and Motor Functions After A Spinal Cord Injury
吗啡对脊髓损伤后感觉和运动功能的影响
  • 批准号:
    7017164
  • 财政年份:
    2005
  • 资助金额:
    $ 6.11万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 6.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 6.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 6.11万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 6.11万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 6.11万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 6.11万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 6.11万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 6.11万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 6.11万
  • 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
  • 批准号:
    10534864
  • 财政年份:
    2023
  • 资助金额:
    $ 6.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了